• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factorial designs for randomized clinical trials.

作者信息

Byar D P, Piantadosi S

出版信息

Cancer Treat Rep. 1985 Oct;69(10):1055-63.

PMID:4042085
Abstract
摘要

相似文献

1
Factorial designs for randomized clinical trials.随机临床试验的析因设计
Cancer Treat Rep. 1985 Oct;69(10):1055-63.
2
Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy.响应面法与用于评估癌症化疗的临床试验设计
Cancer Treat Rep. 1985 Oct;69(10):1049-53.
3
An efficient design for phase III studies of combination chemotherapies.
Cancer Treat Rep. 1985 Oct;69(10):1147-54.
4
Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.基于非计划的期中分析提前终止临床试验：一种序贯设计方法。
Biometrics. 1995 Sep;51(3):1152-62.
5
Strategy and alternate randomized designs in cancer clinical trials.癌症临床试验中的策略与交替随机设计
Cancer Treat Rep. 1982 May;66(5):1095-100.
6
Bayesian adaptive biased-coin designs for clinical trials with normal responses.用于具有正态响应的临床试验的贝叶斯自适应偏币设计
Biometrics. 2005 Mar;61(1):118-25. doi: 10.1111/j.0006-341X.2005.031002.x.
7
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Urol Clin North Am. 1984 May;11(2):319-26.
8
Bayesian design and analysis of two x two factorial clinical trials.两因素二水平析因临床试验的贝叶斯设计与分析
Biometrics. 1997 Jun;53(2):456-64.
9
Perfusion chemotherapy for colorectal liver metastases: a randomized study comparing FUDR against 5-FU/BCNU.结直肠癌肝转移的灌注化疗：一项比较氟尿苷与氟尿嘧啶/卡氮芥的随机研究。
J Chemother. 1989 Jul;1(4 Suppl):1216-7.
10
What can we learn from phase II adjuvant trials in melanoma?我们能从黑色素瘤的II期辅助试验中学到什么？
Br J Cancer. 2000 Jul;83(1):6-7. doi: 10.1054/bjoc.2000.1277.

引用本文的文献

1
Which interactions matter in economic evaluations? A systematic review and simulation study.哪些交互作用在经济评估中重要？一项系统评价和模拟研究。
BMC Med Res Methodol. 2020 May 7;20(1):109. doi: 10.1186/s12874-020-00978-0.
2
Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions.医疗资源配置决策：交互干预的联合决策与单独决策。
Med Decis Making. 2018 May;38(4):476-486. doi: 10.1177/0272989X18758018.
3
Two-by-Two Factorial Cancer Treatment Trials: Is Sufficient Attention Being Paid to Possible Interactions?
二乘二析因癌症治疗试验：是否充分关注了可能的相互作用？
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx146.
4
CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.博茨瓦纳 CYP2B6 基因型与早期依非韦伦为基础的 HIV 治疗结局。
AIDS. 2017 Sep 24;31(15):2107-2113. doi: 10.1097/QAD.0000000000001593.
5
Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.析因随机对照试验的经济学评价：挑战、方法与建议
Stat Med. 2017 Aug 15;36(18):2814-2830. doi: 10.1002/sim.7322. Epub 2017 May 3.
6
Current trends in living donor liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎活体供肝肝移植的当前趋势。
Transplantation. 2011 May 27;91(10):1148-52. doi: 10.1097/TP.0b013e31821694b3.
7
Screening Experiments for Developing Dynamic Treatment Regimes.用于开发动态治疗方案的筛选实验
J Am Stat Assoc. 2009 Mar 1;104(485):391-408. doi: 10.1198/jasa.2009.0119.
8
Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection.决定接受来自高风险血液传播病毒感染供体的肾脏的决定因素。
Clin J Am Soc Nephrol. 2010 May;5(5):917-23. doi: 10.2215/CJN.08251109. Epub 2010 Mar 25.
9
Regulated payments for living kidney donation: an empirical assessment of the ethical concerns.活体肾脏捐献中的监管支付：对伦理问题的实证评估。
Ann Intern Med. 2010 Mar 16;152(6):358-65. doi: 10.7326/0003-4819-152-6-201003160-00005.
10
Developing multicomponent interventions using fractional factorial designs.使用分数析因设计开发多组分干预措施。
Stat Med. 2009 Sep 20;28(21):2687-708. doi: 10.1002/sim.3643.